Genomically Profiling, Collecting, Archiving and Distributing Hematologic Malignancy Specimens

Clinical trial NCT04968834 · RECRUITING

Trial details

NCT number: NCT04968834
Sponsor: Dana-Farber Cancer Institute
Status: RECRUITING
Study type: OBSERVATIONAL

Leukemia Myelodysplastic Syndromes Myeloproliferative Syndrome

Start date: 2021-06-11
Primary completion: 2033-06-01
Enrollment: 300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.